Show simple item record

dc.contributor.authorClark, D.R.
dc.contributor.authorTapia, M.D.
dc.contributor.authorfor BMGF Supported Maternal Influenza Immunization Trials Investigators Group
dc.date.accessioned2020-06-30T18:46:31Z
dc.date.available2020-06-30T18:46:31Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85086346359&doi=10.1097%2fINF.0000000000002629&partnerID=40&md5=db826e1ef3cdd4848ce10a1fa31f9c07
dc.identifier.urihttp://hdl.handle.net/10713/13206
dc.description.abstractThis analysis includes pooled data from 2 placebo-controlled maternal influenza immunization trials, with a separate analysis on a meningococcal conjugate vaccine-controlled maternal influenza immunization trial. Maternal influenza immunization was not associated with infant or maternal all-cause mortality in placebo-controlled trials. In the meningococcal conjugate vaccine-controlled trial, there were fewer deaths during low or any influenza circulation weeks among infants whose mothers received meningococcal conjugate vaccine. ClinicalTrials.gov identifiers: NCT01430689, NCT01034254 and NCT02465190.en_US
dc.description.urihttps://doi.org/10.1097/INF.0000000000002629en_US
dc.language.isoen_USen_US
dc.publisherWolters Kluwer Healthen_US
dc.relation.ispartofThe Pediatric infectious disease journal
dc.subject.meshInfluenza Vaccinesen_US
dc.subject.meshImmunity, Maternally-Acquireden_US
dc.titleInfluenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trialsen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/INF.0000000000002629
dc.identifier.pmid32379201


This item appears in the following Collection(s)

Show simple item record